BACKGROUND:Cerebral oxygenation monitoring may reduce the risk of death and neurologic complications in extremely preterm infants, but no such effects have yet been demonstrated in preterm infants in sufficiently powered randomised clinical trials. The objective of the SafeBoosC III trial is to investigate the benefits and harms of treatment based on near-infrared spectroscopy (NIRS) monitoring compared with treatment as usual for extremely preterm infants. METHODS/DESIGN:SafeBoosC III is an investigator-initiated, multinational, randomised, pragmatic phase III clinical trial. Inclusion criteria will be infants born below 28 weeks postmenstrual age and parental informed consent (unless the site is using 'opt-out' or deferred consent). Exclu...
Near-infrared spectroscopy-derived regional tissue oxygen saturation of haemoglobin (rSto(2)) reflec...
Background: Infants born extremely preterm are at high risk of dying or suffering from severe brain ...
Background: The use of cerebral oximetry monitoring in the care of extremely preterm infants is incr...
BACKGROUND: Cerebral oxygenation monitoring may reduce the risk of death and neurologic complication...
BACKGROUND: Cerebral oxygenation monitoring may reduce the risk of death and neurologic complication...
Background: Cerebral oxygenation monitoring may reduce the risk of death and neurologic complication...
Background: Every year in Europe about 25,000 infants are born extremely preterm. These infants have...
Cerebral oxygenation monitoring may reduce the risk of death and neurologic complications in extreme...
OBJECTIVE To determine if it is possible to stabilise the cerebral oxygenation of extremely preterm...
Objective: To determine if it is possible to stabilise the cerebral oxygenation of extremely preterm...
Background: Every year in Europe about 25,000 infants are born extremely preterm. These infants have...
INTRODUCTION: The research programme Safeguarding the Brains of our smallest Children (SafeBoosC) ai...
BACKGROUND: The SafeBoosC phase II multicentre randomised clinical trial investigated the benefits a...
BACKGROUND: The SafeBoosC phase II multicentre randomized clinical trial investigated the benefits a...
Background:The SafeBoosC phase II multicentre randomized clinical trial investigated the benefits an...
Near-infrared spectroscopy-derived regional tissue oxygen saturation of haemoglobin (rSto(2)) reflec...
Background: Infants born extremely preterm are at high risk of dying or suffering from severe brain ...
Background: The use of cerebral oximetry monitoring in the care of extremely preterm infants is incr...
BACKGROUND: Cerebral oxygenation monitoring may reduce the risk of death and neurologic complication...
BACKGROUND: Cerebral oxygenation monitoring may reduce the risk of death and neurologic complication...
Background: Cerebral oxygenation monitoring may reduce the risk of death and neurologic complication...
Background: Every year in Europe about 25,000 infants are born extremely preterm. These infants have...
Cerebral oxygenation monitoring may reduce the risk of death and neurologic complications in extreme...
OBJECTIVE To determine if it is possible to stabilise the cerebral oxygenation of extremely preterm...
Objective: To determine if it is possible to stabilise the cerebral oxygenation of extremely preterm...
Background: Every year in Europe about 25,000 infants are born extremely preterm. These infants have...
INTRODUCTION: The research programme Safeguarding the Brains of our smallest Children (SafeBoosC) ai...
BACKGROUND: The SafeBoosC phase II multicentre randomised clinical trial investigated the benefits a...
BACKGROUND: The SafeBoosC phase II multicentre randomized clinical trial investigated the benefits a...
Background:The SafeBoosC phase II multicentre randomized clinical trial investigated the benefits an...
Near-infrared spectroscopy-derived regional tissue oxygen saturation of haemoglobin (rSto(2)) reflec...
Background: Infants born extremely preterm are at high risk of dying or suffering from severe brain ...
Background: The use of cerebral oximetry monitoring in the care of extremely preterm infants is incr...